𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma

✍ Scribed by Jean-Claude Bystryn; Ruth Oratz; Daniel Roses; Matthew Harris; Milagros Henn; Robert Lew


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
795 KB
Volume
69
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Induction of strong and persistent Melan
✍ Andrea Tuettenberg; Christian Becker; Eva Huter; JΓΌrgen Knop; Alexander H. Enk; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 607 KB

## Abstract A significant percentage of stage II melanoma patients (tumor thickness >1 mm) remain at risk of tumor recurrence after primary tumor excision. In this study, we used tumor antigen‐pulsed dendritic cells as an adjuvant for immunization of these β€œhigh‐risk” melanoma patients after resect

Malignant melanoma: relationship of the
✍ Jeffrey E. Lee; Meisheng Lu; Paul F. Mansfield; Chris D. Platsoucas; John D. Rev πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 576 KB

## BACKGROUND. Melanoma patients who carry the human leukocyte antigen (HLA) Class I1 allele DQLll\*0301 have an increased frequency of metastases at presentation compared with those lacking HLA-DQB1\*0301. This study was designed to determine whether HLA-DQBI\*0301 is associated with an increased